A tour de force State-of-the-art lecture by Tim Greten at Cholangiocarcinoma Foundation basic science track - From Mice to Men and Back to Mice: Basic and Translational Research Studies in CCA. Highlighting the importance of using the right preclinical models + patient data in a complementary manner.

Jonathan Hernandez from NIH shared clinical trials that are available to patients with #cholangiocarcinoma & some of the results from the trials. Thank you to all the patients who participate in clinical trials which contribute to the development of better treatments. #ccfac24

Accurate representation of racial and ethnic populations in clinical trials is crucial to ensure effective widespread cancer care. A #CCRAdvance found that Hispanic and non-Hispanic black people are underrepresented in many liver cancer trials in the US.

pubmed.ncbi.nlm.nih.gov/38124450

Are Our Clinical Trials at the National Cancer Institute Right for You: Liver Cancer youtu.be/hS0XXudBeEY via YouTube
Tim Greten Donna Hrones NCI Center for Cancer Research NIH NCI CCR Med Onc Service #livercancer

Underrepresentation of Hispanics -Liver Cancer Phase III Trials Tim Greten J. Alberto Maldonado, MS4 @KatherineAMcGlynn NCI Center for Cancer Research NCI CCR Med Onc Service
#healthdisparities #livercancer #Hispanic

Hispanic individuals in liver cancer trial representation | JHC Dove Medical Press dovepress.com/hispanic-indiv…

In times of CART and biespecifics, we celebrate the first auto for #myeloma in the Amazon region reinbursed by the public health system, meaning access to anyone.

Baby step in the technology, but a big step for patient access in a low income region.

I get to learn from some of the best. Lots of laughter, many celebrations, and plenty of debates over the past year with this great team in GI malignancies at the NCI! Happy to see our work together come through. NCI CCR Med Onc Service

Proud to be part of the review on the current landscape in the treatments available for early, intermediate, and advanced stage #HCC ! Cecilia Monge B, MD Tim Greten Kelley Coffman D’Annibale MD Changqing Xie

Excited to see this published: Current Landscape of Therapies for Hepatocellular Carcinoma academic.oup.com/carcin/article…
Tim Greten
grateful to Kelley Coffman D’Annibale MD @changqingxie Shadin Ghabra @donnamabry NCI Center for Cancer Research National Cancer Institute NCI CCR Med Onc Service

Dr. Pellini discusses ctDNA use for maintenance outcomes in patients with NSCLC treated with A + CP

DAVA Oncology #DAVAHawaiiLung

The importance to educate in gastric cancer risk factors and symptoms. Congrats LEGACyH2020 Mexico 🇲🇽 team Erika Ruiz-Garcia #gastriccancerprevention 🙌🏻World Congress on Gastrointestinal Cancer

July is here and so is the VCU School of Population Health! What to expect? More collaboration-team science-research- training and service to our community! Humbled to serve as founding dean with committed faculty, staff and students. #4ourhealth #VCUdidit !

Lenvatinib Plus Pembrolizumab vs Regorafenib or TAS for Previously Treated mCRC: Phase 3 LEAP-017 Study at #WCGIC2023
👉mOS: 9.8 vs 9.3 mo
👉There is some activity, but⛔️
👉IO in MSS CRC remains a challenge...
World Congress on Gastrointestinal Cancer ESMO - Eur. Oncology OncoAlert

Cervical cancer remains a major health problem in Latin America and the Caribbean despite declining trends in incidence over the past decade #GlobOnc #CervicalCancer #HPV #VaccineWorks

hemonc.theclinics.com/article/S0889-…

Honored by the invitation to co-host this Session with Lewis Roberts at the Cholangiocarcinoma Conference - FASEB in California in August, see you there!
Mayo Clinic Comprehensive Cancer Center NCI Center for Cancer Research National Cancer Institute NCI CCR Med Onc Service FASEB

Celebrating my amazing mentee J. Alberto Maldonado, MS4 who worked so hard and did so much for healthcare disparities in liver cancer; especially in Hispanic populations. It was an honor to mentor him! Tim Greten
NCI Center for Cancer Research National Cancer Institute NCI CCR Med Onc Service #LatinosInOncology #disparities #HCC

Thankful for a mentoring team full of wisdom, talent, and laughs. Forever grateful to Cecilia Monge B, MD for always understanding my vision, a true mentor who champions for me even when I’m not there

Also, big thanks to Tim Greten for always reigning in our ideas when needed 😅

Honored by ASCO Trainee and Early Career Oncologist Invitation: Careers in Oncology; Government and Industry Panel Session with outstanding colleagues Neelima Denduluri Brandon Huffman, MD @akinborooladimeji ASCO23 FDA Oncology U.S. FDA NCI CCR Med Onc Service Dana-Farber AstraZenecaUS National Cancer Institute

❤️ Community is key!
#LatinasinOncology ☕️ at #ASCO23
Thank you Narjust Florez, MD, FASCO & Gladys Rodriguez,MD, FASCO for creating this space!
🙏🏽 Conquer Cancer, the ASCO Foundation ASCO Sandra for supporting #LatinosInOncology #LatinasInMedicine community!

Congratulations J. Alberto Maldonado, MS4 well deserved ASCO 👏👏👏👏